"Kanamycin Kinase" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A class of enzymes that inactivate aminocyclitol-aminoglycoside antibiotics (AMINOGLYCOSIDES) by regiospecific PHOSPHORYLATION of the 3' and/or 5' hydroxyl.
Descriptor ID |
D019868
|
MeSH Number(s) |
D08.811.913.696.620.475
|
Concept/Terms |
Kanamycin Kinase- Kanamycin Kinase
- Kinase, Kanamycin
- Aminocyclitol Phosphotransferase
- Phosphotransferase, Aminocyclitol
- Neomycin Phosphotransferase
- Phosphotransferase, Neomycin
- Aminoglycoside Phosphotransferase
- Phosphotransferase, Aminoglycoside
- Kanamycin-Neomycin Phosphate Transferase
- Kanamycin Neomycin Phosphate Transferase
- Phosphate Transferase, Kanamycin-Neomycin
- Transferase, Kanamycin-Neomycin Phosphate
- Amikacin 3'-Phosphotransferase
- 3'-Phosphotransferase, Amikacin
- Amikacin 3' Phosphotransferase
- Aminoglycoside 3'-Phosphotransferase Type VIII
- Aminoglycoside 3' Phosphotransferase Type VIII
APHVII- APHVII
- aphVII Gene Product
|
Below are MeSH descriptors whose meaning is more general than "Kanamycin Kinase".
Below are MeSH descriptors whose meaning is more specific than "Kanamycin Kinase".
This graph shows the total number of publications written about "Kanamycin Kinase" by people in this website by year, and whether "Kanamycin Kinase" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 0 | 3 | 3 |
1997 | 1 | 0 | 1 |
1998 | 0 | 1 | 1 |
2007 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Kanamycin Kinase" by people in Profiles.
-
Craniofacial, skeletal, and cardiac defects associated with altered embryonic murine Zic3 expression following targeted insertion of a PGK-NEO cassette. Front Biosci. 2007 Jan 01; 12:1680-90.
-
Increased transduction efficiency of primary hematopoietic cells by physical colocalization of retrovirus and target cells. J Hematother. 1998 Jun; 7(3):217-24.
-
Comparison of retroviral-mediated gene transfer into cultured human CD34+ hematopoietic progenitor cells derived from peripheral blood, bone marrow, and fetal umbilical cord blood. Biol Blood Marrow Transplant. 1997 Nov; 3(5):273-81.
-
Immunomodulatory effects of human neuroblastoma cells transduced with a retroviral vector encoding interleukin-2. Cancer Gene Ther. 1994 Dec; 1(4):253-8.
-
Assessment of the efficacy of purging by using gene marked autologous marrow transplantation for children with AML in first complete remission. Hum Gene Ther. 1994 Apr; 5(4):481-99.
-
Administration of neomycin-resistance-gene-marked EBV-specific cytotoxic T lymphocytes to recipients of mismatched-related or phenotypically similar unrelated donor marrow grafts. Hum Gene Ther. 1994 Mar; 5(3):381-97.
-
Oncogene expression in retinal horizontal cells of transgenic mice results in a cascade of neurodegeneration. Neuron. 1993 Jun; 10(6):1197-209.
-
Development of a clinical protocol for hepatic gene transfer: lessons learned in preclinical studies. Pediatr Res. 1993 Apr; 33(4 Pt 1):313-20.
-
An approach for the analysis of relapse and marrow reconstitution after autologous marrow transplantation using retrovirus-mediated gene transfer. Blood. 1992 May 15; 79(10):2694-700.
-
Molecular analysis of retroviral transduction in chronic myelogenous leukemia. Hum Gene Ther. 1991; 2(4):317-21.